FI103043B1 - Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet - Google Patents

Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet

Info

Publication number
FI103043B1
FI103043B1 FI923268A FI923268A FI103043B1 FI 103043 B1 FI103043 B1 FI 103043B1 FI 923268 A FI923268 A FI 923268A FI 923268 A FI923268 A FI 923268A FI 103043 B1 FI103043 B1 FI 103043B1
Authority
FI
Finland
Prior art keywords
vinyl
preparation
useful
ethynylquinolone
carboxylic acid
Prior art date
Application number
FI923268A
Other languages
English (en)
Swedish (sv)
Other versions
FI923268A0 (fi
FI103043B (fi
FI923268A (fi
Inventor
Uwe Petersen
Thomas Himmler
Thomas Schenke
Andreas Krebs
Klaus Grohe
Klaus-Dieter Bremm
Karl Georg Metzger
Rainer Endermann
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI923268A0 publication Critical patent/FI923268A0/fi
Publication of FI923268A publication Critical patent/FI923268A/fi
Priority to FI970312A priority Critical patent/FI970312A0/fi
Application granted granted Critical
Publication of FI103043B1 publication Critical patent/FI103043B1/fi
Publication of FI103043B publication Critical patent/FI103043B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
FI923268A 1991-07-19 1992-07-16 Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-ety nyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menete lmässä käyttökelpoiset välituotteet FI103043B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI970312A FI970312A0 (fi) 1991-07-19 1997-01-24 8-halogeenikinoliinikarboksyylihappojohdannaiset

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4123918A DE4123918A1 (de) 1991-07-19 1991-07-19 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
DE4123918 1991-07-19

Publications (4)

Publication Number Publication Date
FI923268A0 FI923268A0 (fi) 1992-07-16
FI923268A FI923268A (fi) 1993-01-20
FI103043B1 true FI103043B1 (fi) 1999-04-15
FI103043B FI103043B (fi) 1999-04-15

Family

ID=6436512

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923268A FI103043B (fi) 1991-07-19 1992-07-16 Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-ety nyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menete lmässä käyttökelpoiset välituotteet

Country Status (22)

Country Link
EP (1) EP0523512B1 (fi)
JP (1) JP3174405B2 (fi)
KR (1) KR100240608B1 (fi)
AT (1) ATE147733T1 (fi)
AU (1) AU658901B2 (fi)
CA (1) CA2073993A1 (fi)
CZ (1) CZ282037B6 (fi)
DE (2) DE4123918A1 (fi)
DK (1) DK0523512T3 (fi)
ES (1) ES2097835T3 (fi)
FI (1) FI103043B (fi)
GR (1) GR3022305T3 (fi)
HU (1) HU219910B (fi)
IE (1) IE80557B1 (fi)
IL (1) IL102520A (fi)
MX (1) MX9204110A (fi)
NO (1) NO302886B1 (fi)
PL (1) PL171910B1 (fi)
RU (1) RU2077533C1 (fi)
SK (1) SK219192A3 (fi)
TW (1) TW201309B (fi)
ZA (1) ZA925351B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4425659A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
ATE269320T1 (de) * 1996-04-19 2004-07-15 Wakunaga Pharma Co Ltd Neue pyridoncarbonsäure-derivate oder salze dieser derivate und antibakterielle mittel, die diese als aktiven wirkstoff enthalten
AU1040597A (en) * 1996-12-04 1998-06-29 Daiichi Pharmaceutical Co., Ltd. Substituted aminomethylpyrrolidine derivatives
TR200001435T2 (tr) 1997-09-15 2000-08-21 The Procter & Gamble Company Antimikrobiyal kuinolonlar, bunların bileşimleri ve kullanımları
US7514451B2 (en) 2003-09-10 2009-04-07 Kyorin Pharmaceutical Co., Ltd. 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
WO2007037303A1 (ja) * 2005-09-28 2007-04-05 Daiichi Sankyo Company, Limited テトラ置換-5-アザスピロ[2.4]へプタン誘導体の製法およびその光学活性中間体
JP5097967B2 (ja) 2006-03-28 2012-12-12 タイゲン バイオテクノロジー カンパニー,リミテッド リンゴ酸塩類、及び(3s,5s)−7−[3−アミノ−5−メチルーピペリジニル]−1−シクロプロピル−1,4−ジヒドロ−8−メトキシ−4−オキソ−3−キノリンカルボン酸の多形体類
KR20110082635A (ko) 2006-03-28 2011-07-19 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
SG11202010024UA (en) * 2018-05-09 2020-11-27 Bayer Animal Health Gmbh New quinoline derivatives
RU2757741C1 (ru) * 2021-03-01 2021-10-21 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123536A (en) * 1977-12-14 1978-10-31 Warner-Lambert Company Dialkyl ({[3-(alkoxycarbonyl)-1,4-dihydro-4-oxo-8-quinolinyl]amino}methylene)propanedioates
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US5047538A (en) * 1990-04-12 1991-09-10 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents

Also Published As

Publication number Publication date
RU2077533C1 (ru) 1997-04-20
KR930002320A (ko) 1993-02-22
SK279221B6 (sk) 1998-08-05
TW201309B (fi) 1993-03-01
HU9202349D0 (en) 1992-10-28
MX9204110A (es) 1993-08-01
AU1966392A (en) 1993-01-21
NO302886B1 (no) 1998-05-04
HUT61741A (en) 1993-03-01
ATE147733T1 (de) 1997-02-15
CZ219192A3 (en) 1993-02-17
DE4123918A1 (de) 1993-01-21
CA2073993A1 (en) 1993-01-20
ZA925351B (en) 1993-04-28
PL295331A1 (en) 1993-07-12
IE922348A1 (en) 1993-01-27
NO922639L (no) 1993-01-20
DE59207880D1 (de) 1997-02-27
ES2097835T3 (es) 1997-04-16
FI923268A0 (fi) 1992-07-16
CZ282037B6 (cs) 1997-04-16
EP0523512B1 (de) 1997-01-15
PL171910B1 (pl) 1997-06-30
GR3022305T3 (en) 1997-04-30
SK219192A3 (en) 1998-08-05
IL102520A0 (en) 1993-01-14
HU219910B (hu) 2001-09-28
JP3174405B2 (ja) 2001-06-11
FI103043B (fi) 1999-04-15
IE80557B1 (en) 1998-09-23
EP0523512A1 (de) 1993-01-20
KR100240608B1 (ko) 2000-03-02
FI923268A (fi) 1993-01-20
JPH05262738A (ja) 1993-10-12
DK0523512T3 (da) 1997-06-30
AU658901B2 (en) 1995-05-04
IL102520A (en) 1997-07-13
NO922639D0 (no) 1992-07-03

Similar Documents

Publication Publication Date Title
FI103043B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet
FI95255C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
FI903696A0 (fi) Menetelmä antibakteeristen 5-alkyyli-6-fluori-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi
FI875413A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten spiro-substituoitujen glutaarihappoamidien valmistamiseksi
ES8204437A1 (es) Un procedimiento para la preparacion de acidos 6-b-hidroxialquilpenicilanicos y sus derivados.
PH25459A (en) Compound useful in the production of quinoline, naphthyridine carboxylic acids useful as antibacterials
FI944164A (fi) Etikkahapon valmistusmenetelmä
FI95704B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI875319A0 (fi) Bisyklisten aminokarboksyylihappojen johdannaiset, menetelmä niiden valmistamiseksi ja niiden valmistuksessa käytettävät välituotteet, sekä niiden käyttö
FI890723A0 (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
FI893677A (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
ES8802508A1 (es) Procedimiento para preparar derivados alquenicos.
DE68926148D1 (de) Solvate von einem Beta-Lactam-Antibiotikum
FI103881B1 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-fenyylisulfonyyliamino(karbonyyli)-pyridiini-2-karboksyylihappoestereiden valmistamiseksi
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
FI895571A0 (fi) Menetelmä kinolonikarboksyylihappovälituotteiden valmistamiseksi
ES2081674T3 (es) Derivados antibacterianos de los acidos 7-(aminometil-oxa-7-aza-biciclo-(3.3.0.)oct-7-il)quinolon- y naftiridon-carboxilico.
FI905912A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 6-(1-hydroksietyyli)-3-(substituoitu tio)-7-okso-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
FI934054A0 (fi) Menetelmä antibakteeristen karboksyylihappojohdannaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi
NO165839C (no) Mellomprodukter for fremstilling av 5r,65-6-(1r-1-hydroksyetyl)-2-(1-okso-3-tiolanyltio-2-penem-3-karboksylsyrer ogfremgangsmaate for fremstilling av mellomproduktene.
ATE132865T1 (de) 3-anilino-2-hydroxycarbonyl-4-thiophenessigsäur n
ES2095831T3 (es) Acidos tetrahidro-4-fenilimino-3-tiofeno-aceticos.
ATE66453T1 (de) Herstellung von zwischenverbindungen fuer leukotrien-antagonisten.
FI901520A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kefeemikarbonyylihappoesterien valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BAYER AKTIENGESELLSCHAFT